References
- 1Bhidayasiri R, Tarsy D.
Neuropathic Tremor. In: Movement Disorders: A Video Atlas. Current Clinical Neurology 2012. Humana, Totowa, NJ. DOI: 10.1007/978-1-60327-426-5_34 - 2Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021; 12:
684835 . DOI: 10.3389/fneur.2021.684835 - 3Kumar R, Blackband J, Jain V, et al. Roussy-Lévy Syndrome: Pes Cavus, Tendon Areflexia, Amyotrophy, Gait Ataxia, and Upper Limb Tremor in a Patient with CMT Neuropathy. Tremor Other Hyperkinet Mov (N Y). 2024; 14: 6. DOI: 10.5334/tohm.846
- 4Saifee TA, Schwingenschuh P, Reilly MM, et al. Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2013; 84: 1282–1287. DOI: 10.1136/jnnp-2012-303013
- 5Cao Y, Menon P, Ching-Fen Chang F, et al. Postural tremor and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2017; 55: 338–343. DOI: 10.1002/mus.25253
- 6Lenka A, Jankovic J. Peripherally-induced Movement Disorders: An Update. Tremor Other Hyperkinet Mov (N Y). 2023; 13: 8. DOI: 10.5334/tohm.758
- 7Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019; 15: 671–683. DOI: 10.1038/s41582-019-0250-9
- 8Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011; 36: 123–133. DOI: 10.1159/000324710
- 9Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998; 44: 780–788. DOI: 10.1002/ana.410440512
- 10Hosokawa T, Nakajima H, Unoda K, et al. An electrophysiological classification associated with Guillain-Barré syndrome outcomes. J Neurol. 2014; 261: 1986–1993. DOI: 10.1007/s00415-014-7452-2
- 11Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137(Pt 1): 33–43. DOI: 10.1093/brain/awt285
- 12Paternostro-Sluga T, Grim-Stieger M, Posch M, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008; 40: 665–671. DOI: 10.2340/16501977-0235
- 13van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol. 2007; 6: 589–94. DOI: 10.1016/S1474-4422(07)70130-8
- 14Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J; TRS study group. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord. 2007; 22: 833–838. DOI: 10.1002/mds.21412
- 15Elble R, Bain P, Forjaz MJ, et al. Task force report: scales for screening and evaluating tremor: critique and recommendations. Mov Disord. 2013; 28: 1793–800. DOI: 10.1002/mds.25648
- 16Louis ED. Essential tremor. Handb Clin Neurol. 2023; 196: 389–401. DOI: 10.1016/B978-0-323-98817-9.00012-0
- 17Rajan R, Anandapadmanabhan R, Vishnoi A, et al. Neuropathic Tremor in Guillain-Barré Syndrome. Mov Disord Clin Pract. 2023; 10: 1333–1340. DOI: 10.1002/mdc3.13807
- 18Louis ED, Ferrer M, Eliasen EH, Gaini S, Petersen MS. Tremor in normal adults: A population-based study of 1158 adults in the Faroe Islands. J Neurol Sci. 2019; 400: 169–174. DOI: 10.1016/j.jns.2019.03.019
- 19Devaux JJ, Miura Y, Fukami Y, et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology. 2016; 86: 800–807. DOI: 10.1212/WNL.0000000000002418
- 20Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014; 82: 879–886. DOI: 10.1212/WNL.0000000000000205
- 21Bailly L, Mongin M, Delorme C, et al. Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 606. DOI: 10.5334/tohm.451
- 22Cortese A, Lombardi R, Briani C, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm. 2019; 7:
e639 . DOI: 10.1212/NXI.0000000000000639 - 23Saifee TA, Pareés I, Kassavetis P, et al. Tremor in Charcot-Marie-Tooth disease: No evidence of cerebellar dysfunction. Clin Neurophysiol. 2015; 126: 1817–1824. DOI: 10.1016/j.clinph.2014.12.023
- 24Schwingenschuh P, Saifee TA, Katschnig-Winter P, et al. Cerebellar learning distinguishes inflammatory neuropathy with and without tremor. Neurology. 2013; 80: 1867–1873. DOI: 10.1212/WNL.0b013e318292a2b8
- 25Kuo SH, Louis ED. Studying cerebellar dysfunction in neuropathy-related tremor. Clin Neurophysiol. 2015; 126: 1645–1646. DOI: 10.1016/j.clinph.2015.01.003
- 26Wasielewska A, Rudziska M, Tomaszewski T, et al. Tremor in neuropathies of different origin. Neurol Neurochir Pol. 2013; 47: 525–533. DOI: 10.5114/ninp.2013.34695
- 27Benbadis SR, Chen S, Melo M. What’s shaking in the ICU? The differential diagnosis of seizures in the intensive care setting. Epilepsia. 2010; 51: 2338–2340. DOI: 10.1111/j.1528-1167.2010.02683.x
- 28Alonso-Navarro H, Fernández-Díaz A, Martín-Prieto M, Ruiz-Ezquerro JJ, López-Alburquerque T, Jiménez-Jiménez FJ. Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: treatment with pregabalin. Clin Neuropharmacol. 2008; 31: 241–244. DOI: 10.1097/WNF.0b013e3181585b71